Investing
-
Regeneron Acquires 23andMe’s Gene-Testing Business for Drug Discovery
Regeneron Pharmaceuticals, a leading biotechnology company specializing in the development of medicines, has acquired 23andMe’s…
-
Headline: UBS Report Highlights Shifting Landscape of Fundraising Success
The fundraising landscape is constantly evolving, with significant changes impacting which organizations and causes thrive,…
-
Norway Plans Grocery Market Overhaul to Fight Rising Food Costs
Norway’s government is taking steps to increase competition within its grocery market in an effort…
-
US 30-Year Treasury Yield Climbs to 2023 High Following Moody’s Downgrade
The yield on the US 30-year Treasury bond reached its highest level since 2023 recently.…
-
Ark Invest’s Cathie Wood Outlines Views on AI, Tech, and the US Economy
Ark Invest CEO Cathie Wood recently shared her firm’s investment outlook across several key sectors,…
-
Ant Group’s Global Unit Secures $3 Billion Investment, Eyes Spinoff
Ant Group’s international unit, known as Ant International, has secured a significant investment of $3…
-
Moody’s Downgrade of US Credit Sparks Market Concerns
Moody’s, a prominent credit rating agency, recently downgraded its outlook on the United States government’s…
Featured Articles
Search
Author Details
Samantha Blake
Covers major geopolitical events, humanitarian crises, and global policy shifts across continents. Driven by a mission to humanize international news and challenge indifference. Believes that every headline holds a human story — and it deserves to be told with depth, empathy, and integrity